Journal of Shandong University (Health Sciences) ›› 2020, Vol. 58 ›› Issue (2): 54-59.doi: 10.6040/j.issn.1671-7554.0.2019.1268

Previous Articles     Next Articles

Clinics, pathology and prognosis of 30 children with nephrotic syndrome in clinical trials of lupus nephritis

KAN Nana, YU Lichun, SUN Shuzhen, LI Qian, LUAN Chunli   

  1. Department of Pediatric Kidney Rheumatology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, Shandong, China
  • Online:2020-02-10 Published:2022-09-27

Abstract: Objective To summarize the clinical and pathological characteristics of children with nephrotic syndrome(NS)in clinical trials of lupus nephritis(LN), analyze the treatment plan and prognosis, and provide reference for the diagnosis and treatment. Methods Clinical data of children diagnosed with NS-type LN were collected for retrospective analysis from January 1, 2009 to December 31, 2018. Results NS was found in 30 cases(28.0%)of 107 cases with LN. The ages of onset were 5-13 years, average(9.7±2.3)years. Among them, there were 6 males and 24 females with a male to female ratio of 1∶4. The most common extrarenal manifestation is anemia. Compared with non-NS-type LN patients, the proportion of acute kidney injury and hypertension was higher and the proportion of leukopenia was lower in NS-type LN patients(P<0.001;P<0.001; P=0.01). Renal biopsy showed the most common is class Ⅳ(54.5%), followed by class Ⅴ(22.7%), Ⅱ(13.6%), Ⅴ + Ⅱ(4.5%)and Ⅴ + Ⅳ(4.5%)in 22 cases. Thirty cases were given prednisone plus immunosuppressant, including intravenous methylprednisolone pulses(MMP)combined with cyclophosphamide(CTX)(63.3%), sequential usage of mycophenolate mofetil(MMF)after MMP(3.3%), only with CTX(10.0%), MMF combined with tacrolimus(6.7%), only with MMF(3.3%), and poor medication 山 东 大 学 学 报 (医 学 版)58卷2期 -阚娜娜,等.儿童肾病综合征型狼疮性肾炎30例临床、病理及近期疗效观察 \=-compliance(13.3%). After 6 months of treatment, 17 cases had complete remission, 8 cases had partial remission, 4 cases had no remission, and 1 case had died of severe pneumonia and severe sepsis. Conclusion The proportion of acute kidney injury and high blood pressure in NS-type LN patients is high than those in non-NS-type LN patients. In NS-type LN patients, the renal pathology is complex, and class Ⅳ type is the main pathological type. Among the patients with NS-type LN or pathological type of Ⅳ, MMP joint CTX is the main induction therapy, which can effectively induce remission.

Key words: Lupus nephritis, Nephrotic syndrome, Clinical, Prognosis, Children

CLC Number: 

  • R725
[1] Harry O, Yasin S, Brunner H. Childhood-onset systemic lupus erythematosus: a review and update[J]. J Pediatr, 2018, 196: 22-30. e2. doi: 10.1016/j.jpeds.2018.01.045.
[2] Hiraki LT, Benseler SM, Tyrrell PN, et al. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study[J]. J Pediatr, 2008, 152(4): 550-556.
[3] Zhang CX, Cai L, Zhou ZY, et al. Clinical manifestations, immunological features and prognosis of Chinese pediatric systemic lupus erythematosus: a single-center study[J]. Int J Rheum Dis, 2019, 22(6): 1070-1076.
[4] Gomez Mendez LM, Cascino MD, Katsumoto TR, et al. Outcome of participants with nephrotic syndrome in combined clinical trials of lupus nephritis[J]. Lupus Sci Med, 2019, 6(1): e000308. doi: 10.1136/lupus-2018-000308.
[5] 成学琴,鲍华英,张爱华,等. 儿童狼疮性肾炎45例临床、病理及免疫学分析[J]. 临床儿科杂志, 2014, 32(3): 246-249. CHENG Xueqin, BAO Huaying, ZHANG Aihua, et al. Clinical and immunological features of 45 children with lupus nephritis[J]. J Clin Pediatr, 2014, 32(3): 246-249.
[6] Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus[J]. Arthritis Rheum, 2012, 64(8): 2677-2686.
[7] Gipson DS, Massengill SF, Yao L, et al. Management of childhood onset nephrotic syndrome[J]. Pediatrics, 2009, 124(2): 747-757.
[8] Weening JJ, DAgati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited[J]. J Am Soc Nephrol, 2004, 65(2): 521-530.
[9] Radhakrishnan J, Cattran DC. The KDIGO practice guideline on glomerulonephritis: reading between the(guide)lines - application to the individual patient[J]. Kidney Int, 2012, 82(8): 840-856.
[10] Abdel-Nabi HH, Abdel-Noor RA. Comparison between disease onset patterns of Egyptian juvenile and adult systemic lupus erythematosus(single centre experience)[J]. Lupus, 2018, 27(6): 1039-1044.
[11] Levy DM, Kamphuis S. Systemic lupus erythematosus in children and adolescents[J]. Pediatr Clin North Am, 2012, 59(2): 345-364.
[12] Lionaki S, Liapis G, Boletis JN. Pathogenesis and management of acute kidney injury in patients with nephrotic syndrome due to primary glomerulopathies[J]. Medicina(Kaunas), 2019, 55(7). pii: E365. doi: 10.3390/medicina55070365.
[13] Jin SY, Huang DL, Dang XQ, et al. Lupus glomerulonephritis in 788 Chinese children: a multi-centre clinical and histopathological analysis based on 549 renal biopsies[J]. Paediatr Int Child Health, 2017, 37(4): 286-291.
[14] Mahmoud SS, Bazaraa HM, Lotfy HM, et al. Renal involvement in childhood-onset systemic lupus erythematosus in Egypt[J]. Rheumatol Int, 2012, 32(1): 47-51.
[15] Cabral M, Escobar C, Conde M, et al. Juvenile systemic lupus erythematosus in Portugal: clinical and immunological patterns of disease expression in a cohort of 56 patients[J]. Acta Reumatol Port, 2013, 38(4): 274-285.
[16] Abdel-Hafez MA, Abdel-Nabi H. Juvenile systemic lupus erythematosus: onset patterns and short-term outcome in Egyptian children, a single-center experience[J]. Lupus, 2015, 24(13): 1455-1461.
[17] Fayyaz A, Igoe A, Kurien BT, et al. Haematological manifestations of lupus[J]. Lupus Sci Med, 2015, 2(1): e000078. doi: 10.1136/lupus-2014-000078.
[18] Gigante A, Barbano B, Sardo L, et al. Hypercoagulability and nephrotic syndrome[J]. Curr Vasc Pharmacol, 2014, 12(3): 512-517.
[19] Kerlin BA, Ayoob R, Smoyer WE. Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease[J]. Clin J Am Soc Nephrol, 2012, 7(3): 513-520.
[20] Perico N, Remuzzi G. Edema of the nephrotic syndrome: the role of the atrial peptide system[J]. Am J Kidney Dis, 1993, 22(3): 355-366.
[21] Appenzeller S, Cendes F, Costallat LT. Epileptic seizures in systemic lupus erythematosus[J]. Neurology, 2004, 63(10): 1808-1812.
[22] Mikdashi J, Krumholz A, Handwerger B. Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus[J]. Neurology, 2005, 64(12): 2102-2107.
[23] Hanly JG, Urowitz MB, Su L, et al. Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study[J]. Ann Rheum Dis, 2012, 71(9): 1502-1509.
[24] Copple SS, Sawitzke AD, Wilson AM, et al. Enzyme-linked immunosorbent assay screening then indirect immunofluorescence confirmation of antinuclear antibodies: a statistical analysis[J]. Am J Clin Pathol, 2011, 135(5): 678-684.
[25] Katsuno T, Ozaki T, Ozeki T, et al. Investigation on the benefits of mycophenolate mofetil and therapeutic drug monitoring in the treatment of Japanese patients with lupus nephritis[J]. Clin Exp Nephrol, 2018, 22(6): 1341-1350.
[26] Lau KK, Ault BH, Jones DP, et al. Induction therapy for pediatric focal proliferative lupus nephritis: cyclophosphamide versus mycophenolate mofetil[J]. J Pediatr Health Care, 2008, 22(5): 282-288.
[27] Smith E, Al-Abadi E, Armon K, et al. Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis[J]. Lupus, 2019, 28(5): 613-620.
[28] Ginzler EM, Dooley MA, Aranow C, et al. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis[J]. N Engl J Med, 2005, 353(21): 2219-2228.
[29] An Y, Zhou Y, Bi L, et al. Combined immunosuppressive treatment(CIST)in lupus nephritis: a multicenter, randomized controlled study[J]. Clin Rheumatol, 2019, 38(4): 1047-1054.
[30] 孙利,徐虹,刘海梅,等.上海单中心101例儿童狼疮性肾炎的长期随访分析[J].中华儿科杂志, 2011, 49(11): 819-824. SUN Li, XU Hong, LIU Haimei, et al. Long-term follow-up of 101 cases with pediatric lupus nephritis in a single center in Shanghai[J]. Chin J Pediatr, 2011, 49(11): 819-824.
[1] MA Xiang, ZHAO Feiyan. Status and progress of oocyte cryopreservation [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 19-23.
[2] ZHENG Su, CHEN Shuhua, LI Hua, DENG Jie, CHEN Chunhong, WANG Xiaohui, FENG Weixing, HAN Xiaodi, ZHANG Yujia, LI Na, LI Mo, FANG Fang. Correlation between EEG variations and BASED evaluation of the efficacy of ACTH treatment in 54 cases of infantile spasms [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 91-96.
[3] WANG Lihui, GAO Min, KONG Beihua. Angiosarcoma of the uterus: a report of 2 cases and literature review [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 108-112.
[4] HAN Jing, JIA Chunling. Effects of periodontal basic therapy on postoperative pneumonia in patients with lung cancer before thoracic surgery [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 113-118.
[5] HE Shiqing, LI Wanwan, DONG Shuqing, MOU Jingyi, LIU Yuying, WEI Siyu, LIU Zhao, ZHANG Jiaxin. Construction of a prognostic risk model of pyroptosis-related genes in breast cancer based on database [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 34-43.
[6] ZHANG Yufeng, XU Min, XING Xiuli, PANG Shuguang, HU Keqing. Epidemiological characteristics of 689 patients with non-ST-segment elevation myocardial infarction [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 118-122.
[7] SUN Haoyu, JIANG Xin, CHEN Shouzhen, QU Sifeng, SHI Benkang. Multiparametric magnetic resonance imaging combined with prostate health index in the diagnosis of prostate cancer in 142 patients within PSA grey zone [J]. Journal of Shandong University (Health Sciences), 2022, 60(6): 46-50.
[8] ZHAO Haiqing, LI Baomin, YANG Xiaofan, ZHANG Tong, LI Jun, ZHAO Yongheng, GAO Liang. Acute intermittent porphyria with infantile spasm: a case report and literature review [J]. Journal of Shandong University (Health Sciences), 2022, 60(6): 82-89.
[9] ZHAO Yang, KONG Fanlei, LI Shixue. Influence of the gender of children being followed on the subjective well-being of the 656 MEFC in Jinan [J]. Journal of Shandong University (Health Sciences), 2022, 60(6): 122-128.
[10] GONG Yu, GAO Zhen, WANG Huqing, YANG Jingwen, ZHANG Guilian, ZHAN Shuqin, ZHANG Ru, WU Haiqin. Clinical and imaging characteristics of 4 cases of secondary hypertrophic olivary degeneration [J]. Journal of Shandong University (Health Sciences), 2022, 60(5): 37-42.
[11] LI Linlin, WANG Kai. Prediction of hepatocellular carcinoma prognostic genes based on bioinformatics [J]. Journal of Shandong University (Health Sciences), 2022, 60(5): 50-58.
[12] KONG Xinxin, SUN Shuzhen, LI Qian, CHEN Yuan, ZHOU Aihua, WANG Li, YAO Xiujun. Analysis of 7 cases of anti-H factor antibody-positive hemolytic uremic syndrome [J]. Journal of Shandong University (Health Sciences), 2022, 60(4): 82-86.
[13] XUE Ning, GUO Qingwei. Clinical analysis of 32 cases of ingested super absorbent polymer balls in children [J]. Journal of Shandong University (Health Sciences), 2022, 60(2): 65-68.
[14] Chuanxin WANG. Liquid biopsy of tumor [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 64-71.
[15] CHEN Wei, GUO Qingqing, XU Jin, FANG Yuan, SUN Mei, SHENG Yan. A comparative analysis of the effects of natural cycle combined with luteal ovarian stimulation and dual ovarian stimulation [J]. Journal of Shandong University (Health Sciences), 2021, 59(8): 61-66.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!